Eptifibatide Acetate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Specification: >80%
• HS Code: 2937190090
• Production Capacity: 100000g/Month

Product Description

    Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.

Product Introduction
 

Generic name	Eptifibatide Acetate
Formula	C35H49N11O9S2
CAS No.	188627-80-7
Molecular Weight	831.96
EINECS	641-366-7
Density	1.62g/cm^3
Storage Condition	-20ºC
Refractive Index	1.742
Source	Synthetic

Application & Efficacy

       Eptifibatide is used for the treatment of acute coronary syndrome and for the treatment of patients undergoing percutaneous coronary intervention, including those undergoing intracoronary stenting. For acute coronary syndrome, eptifibatide decreases the likelihood of death or new myocardial infarction. Eptifibatide is usually administered in combination with aspirin and heparin.